$EGRX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in EAGLE PHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in EAGLE PHARMACEUTICALS, INC.. Get notifications about new insider transactions in EAGLE PHARMACEUTICALS, INC. for free.

Page:   < prev 1 2 3 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 29 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS83.011,600132,81623,27424.9 K to 23.3 K (-6.43 %)
Mar 29 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS83.001,300107,90024,87426.2 K to 24.9 K (-4.97 %)
Mar 29 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS83.0150041,5056,7777.3 K to 6.8 K (-6.87 %)
Mar 29 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS83.0040033,2007,2777.7 K to 7.3 K (-5.21 %)
Mar 29 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS83.0158,7554,877,2533,675,4193.7 M to 3.7 M (-1.57 %)
Mar 29 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS83.026,182513,2303,734,1743.7 M to 3.7 M (-0.17 %)
Mar 29 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS83.0037,7313,131,6733,740,3563.8 M to 3.7 M (-1.00 %)
Mar 24 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseM12.635,00063,15015,000
Mar 24 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseM12.672,02525,6574,850
Mar 24 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseM12.672,07726,3166,875
Mar 24 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseM4.425,02322,202457
Mar 24 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...SellS82.067,025576,48907 K to 0 (-100.00 %)
Mar 24 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...BuyM12.635,00063,1507,0252 K to 7 K (+246.91 %)
Mar 24 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...BuyM12.672,02525,6572,0250 to 2 K
Mar 24 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...SellS80.097,100568,64107.1 K to 0 (-100.00 %)
Mar 24 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...BuyM12.672,07726,3167,1005 K to 7.1 K (+41.35 %)
Mar 24 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...BuyM4.425,02322,2025,0230 to 5 K
Mar 23 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS83.0170058,1073,778,0873.8 M to 3.8 M (-0.02 %)
Mar 23 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS83.1050041,5503,778,7873.8 M to 3.8 M (-0.01 %)
Mar 22 2017EGRXEAGLE PHARMACEUTIC ...Edlin Richard A.DirectorBuyP79.446,000476,64029,40023.4 K to 29.4 K (+25.64 %)
Mar 21 2017EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...BuyP83.98615,123511450 to 511 (+13.56 %)
Mar 21 2017EGRXEAGLE PHARMACEUTIC ...Edlin Richard A.DirectorOption ExerciseA81.2710,000812,70010,000
Mar 20 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS82.1051,8834,259,5943,779,2873.8 M to 3.8 M (-1.35 %)
Mar 20 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS82.0138,9973,198,1443,831,1703.9 M to 3.8 M (-1.01 %)
Mar 20 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS82.089,120748,5703,870,1673.9 M to 3.9 M (-0.24 %)
Mar 10 2017EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...BuyP77.8445035,0284500 to 450
Jan 06 2017EGRXEAGLE PHARMACEUTIC ...RIGGS DAVID EChief Financial Off ...Option ExerciseA84.9240,0003,396,80040,000
Jan 06 2017EGRXEAGLE PHARMACEUTIC ...Graves MichaelDirectorOption ExerciseA84.9210,000849,20010,000
Jan 06 2017EGRXEAGLE PHARMACEUTIC ...Glenning RobertDirectorOption ExerciseA84.9210,000849,20010,000
Jan 06 2017EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorOption ExerciseA84.9210,000849,20010,000
Jan 06 2017EGRXEAGLE PHARMACEUTIC ...FLAUM SANDER ADirectorOption ExerciseA84.9210,000849,20010,000
Jan 06 2017EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOOption ExerciseA84.92200,90017,060,428200,900
Jan 06 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseA84.9242,0003,566,64042,000
Jan 06 2017EGRXEAGLE PHARMACEUTIC ...Braunstein Douglas LDirectorOption ExerciseA84.9210,000849,20010,000
Jan 06 2017EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...Option ExerciseA84.9290,0007,642,80090,000
Jan 06 2017EGRXEAGLE PHARMACEUTIC ...Hepner AdrianEVP and Chief Medic ...Option ExerciseA84.9267,2005,706,62467,200
Jan 06 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS85.1665,1145,545,1083,879,2873.9 M to 3.9 M (-1.65 %)
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseM46.095,127236,30353,464
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseM46.095,126236,25758,591
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseM46.097,569348,85563,717
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseM12.632,68333,88620,000
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseM12.6310,000126,30022,683
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseM12.637,31792,41432,683
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseM12.672,68333,9948,952
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseM12.676,27079,44111,635
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseM4.423,73016,4875,480
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...SellS78.615,127403,01805.1 K to 0 (-100.00 %)
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...BuyM46.095,127236,3035,1270 to 5.1 K
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...SellS76.785,126393,57105.1 K to 0 (-100.00 %)
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...BuyM46.095,126236,2575,1260 to 5.1 K
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...SellS77.177,569584,13507.6 K to 0 (-100.00 %)
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...BuyM46.097,569348,8557,5690 to 7.6 K
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...SellS77.172,683207,06002.7 K to 0 (-100.00 %)
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...BuyM12.632,68333,8862,6830 to 2.7 K
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...SellS76.6910,000766,876010 K to 0 (-100.00 %)
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...BuyM12.6310,000126,30010,0000 to 10 K
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...SellS75.617,317553,21307.3 K to 0 (-100.00 %)
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...BuyM12.637,31792,4147,3170 to 7.3 K
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...SellS75.612,683202,85302.7 K to 0 (-100.00 %)
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...BuyM12.672,68333,9942,6830 to 2.7 K
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...SellS74.796,270468,93106.3 K to 0 (-100.00 %)
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...BuyM12.676,27079,4416,2700 to 6.3 K
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...SellS74.793,730278,96503.7 K to 0 (-100.00 %)
Jan 04 2017EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...BuyM4.423,73016,4873,7300 to 3.7 K
Dec 15 2016EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseM4.4210,00044,2009,210
Dec 15 2016EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...SellS73.6210,000736,163010 K to 0 (-100.00 %)
Dec 15 2016EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...BuyM4.4210,00044,20010,0000 to 10 K
Dec 14 2016EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorSellS75.008,700652,50013,32422 K to 13.3 K (-39.50 %)
Dec 14 2016EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorSellS75.071,30097,59122,02423.3 K to 22 K (-5.57 %)
Dec 14 2016EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorBuyP12.793,95050,52123,32419.4 K to 23.3 K (+20.39 %)
Dec 02 2016EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseM4.421,3075,77719,210
Dec 02 2016EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseM8.782,53022,2130
Dec 02 2016EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseM8.781,95017,1210
Dec 02 2016EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseM8.782001,7562,530
Dec 02 2016EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...SellS80.001,307104,56001.3 K to 0 (-100.00 %)
Dec 02 2016EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...BuyM4.421,3075,7771,3070 to 1.3 K
Dec 02 2016EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...SellS80.002,530202,40002.5 K to 0 (-100.00 %)
Dec 02 2016EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...BuyM8.782,53022,2132,5300 to 2.5 K
Dec 02 2016EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...SellS80.001,950156,00002 K to 0 (-100.00 %)
Dec 02 2016EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...BuyM8.781,95017,1211,9500 to 2 K
Dec 02 2016EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...SellS80.0020016,0000200 to 0 (-100.00 %)
Dec 02 2016EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...BuyM8.782001,7562000 to 200
Nov 30 2016EGRXEAGLE PHARMACEUTIC ...FLAUM SANDER ADirectorSellS78.665,000393,30011,37416.4 K to 11.4 K (-30.54 %)
Nov 14 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS85.0015,5511,321,8353,944,4014 M to 3.9 M (-0.39 %)
Nov 14 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS85.001,300110,50026,17427.5 K to 26.2 K (-4.73 %)
Nov 14 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS85.0030025,5007,6778 K to 7.7 K (-3.76 %)
Nov 14 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS87.051,700147,9853,959,9524 M to 4 M (-0.04 %)
Nov 14 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS86.061008,6063,961,6524 M to 4 M (0.00 %)
Nov 14 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS86.0016714,3623,961,7524 M to 4 M (0.00 %)
Nov 14 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS85.1015,3681,307,8173,961,9194 M to 4 M (-0.39 %)
Nov 09 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS80.09102,9198,242,7833,977,2874.1 M to 4 M (-2.52 %)
Nov 09 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS79.2419,5811,551,5984,080,2064.1 M to 4.1 M (-0.48 %)
Nov 09 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS78.234,200328,5664,099,7874.1 M to 4.1 M (-0.10 %)
Nov 09 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS77.139,030696,4844,103,9874.1 M to 4.1 M (-0.22 %)
Nov 09 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS76.4911,690894,1684,113,0174.1 M to 4.1 M (-0.28 %)
Nov 09 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS75.701,380104,4664,124,7074.1 M to 4.1 M (-0.03 %)
Nov 09 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS75.395,030379,2124,126,0874.1 M to 4.1 M (-0.12 %)
Nov 04 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS75.0046,1703,462,7504,181,4464.2 M to 4.2 M (-1.09 %)
Nov 04 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS70.002,100147,00027,47429.6 K to 27.5 K (-7.10 %)
Nov 04 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS70.0080056,0007,9778.8 K to 8 K (-9.11 %)
Nov 04 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS70.4150,3293,543,6654,177,2874.2 M to 4.2 M (-1.19 %)
Nov 04 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS70.00146,37110,245,9704,227,6164.4 M to 4.2 M (-3.35 %)
Oct 04 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS70.0622,1001,548,3264,373,9874.4 M to 4.4 M (-0.50 %)
Sep 30 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS70.0477,9005,456,1164,396,0874.5 M to 4.4 M (-1.74 %)
Sep 23 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS66.1765443,27529,57430.2 K to 29.6 K (-2.16 %)
Sep 23 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS66.1719412,8378,7779 K to 8.8 K (-2.16 %)
Sep 23 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS67.241,798120,8984,473,9874.5 M to 4.5 M (-0.04 %)
Sep 23 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS66.1597,1496,426,4064,475,7854.6 M to 4.5 M (-2.12 %)
Sep 08 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS62.3322413,96230,22830.5 K to 30.2 K (-0.74 %)
Sep 08 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS62.33664,1148,9719 K to 9 K (-0.73 %)
Sep 08 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS62.3333,7962,106,5054,572,9344.6 M to 4.6 M (-0.73 %)
Sep 08 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS62.26754,67030,45230.5 K to 30.5 K (-0.25 %)
Sep 08 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS62.26221,3709,0379.1 K to 9 K (-0.24 %)
Sep 08 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS62.2611,345706,3404,606,7304.6 M to 4.6 M (-0.25 %)
Sep 08 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS62.8316610,43030,52730.7 K to 30.5 K (-0.54 %)
Sep 08 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS62.83493,0799,0599.1 K to 9.1 K (-0.54 %)
Sep 08 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS63.2512,224773,1684,618,0754.6 M to 4.6 M (-0.26 %)
Sep 08 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS62.4512,958809,2274,630,2994.6 M to 4.6 M (-0.28 %)
Aug 25 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS62.78764,77130,69330.8 K to 30.7 K (-0.25 %)
Aug 25 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS62.78231,4449,1089.1 K to 9.1 K (-0.25 %)
Aug 25 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS62.7811,506722,3474,643,2574.7 M to 4.6 M (-0.25 %)
Aug 25 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS63.121137,13330,76930.9 K to 30.8 K (-0.37 %)
Aug 25 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS63.12342,1469,1319.2 K to 9.1 K (-0.37 %)
Aug 25 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS63.1417,1181,080,8314,654,7634.7 M to 4.7 M (-0.37 %)
Aug 17 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS61.00965,85630,88231 K to 30.9 K (-0.31 %)
Aug 17 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS61.00291,7695,3875.4 K to 5.4 K (-0.54 %)
Aug 17 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS61.199,848602,5994,671,7794.7 M to 4.7 M (-0.21 %)
Aug 17 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS60.854,723287,3954,681,6274.7 M to 4.7 M (-0.10 %)
Aug 17 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS60.7839423,94730,97831.4 K to 31 K (-1.26 %)
Aug 17 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS60.781177,1115,4165.5 K to 5.4 K (-2.11 %)
Aug 17 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS62.2131,5991,965,7744,686,3504.7 M to 4.7 M (-0.67 %)
Aug 17 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS61.6511,770725,6214,717,9494.7 M to 4.7 M (-0.25 %)
Aug 17 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS60.6616,270986,9384,729,7194.7 M to 4.7 M (-0.34 %)
Aug 17 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS60.701639,89431,37231.5 K to 31.4 K (-0.52 %)
Aug 17 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS60.70492,9745,5335.6 K to 5.5 K (-0.88 %)
Aug 17 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS61.318,070494,7724,745,9894.8 M to 4.7 M (-0.17 %)
Aug 17 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS60.5116,6671,008,5204,754,0594.8 M to 4.8 M (-0.35 %)
Aug 04 2016EGRXEAGLE PHARMACEUTIC ...Graves MichaelDirectorOption ExerciseA46.6615,000699,90015,000
Jul 06 2016EGRXEAGLE PHARMACEUTIC ...Braunstein Douglas LDirectorOption ExerciseA41.0110,000410,10010,000
Jul 06 2016EGRXEAGLE PHARMACEUTIC ...Glenning RobertDirectorOption ExerciseA41.0110,000410,10010,000
Jun 30 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Financial LLC10% OwnerSellJ0.009,90305,58215.5 K to 5.6 K (-63.95 %)
May 24 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Management LLC10% OwnerSellJ0.009,36009,36018.7 K to 9.4 K (-50.00 %)
May 24 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Management LLC10% OwnerSellJ0.004,770,82804,770,8289.5 M to 4.8 M (-50.00 %)
May 16 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Management LLC10% OwnerSellS40.9213,980572,06241,08155.1 K to 41.1 K (-25.39 %)
May 16 2016EGRXEAGLE PHARMACEUTIC ...ProQuest Management LLC10% OwnerSellS40.004,000160,00055,06159.1 K to 55.1 K (-6.77 %)
Apr 05 2016EGRXEAGLE PHARMACEUTIC ...Tarriff ScottPresident and CEOSellS40.6330,7651,249,9821,369,9461.4 M to 1.4 M (-2.20 %)
Mar 16 2016EGRXEAGLE PHARMACEUTIC ...Graves MichaelDirectorBuyP56.731,00056,7301,0000 to 1,000
Mar 03 2016EGRXEAGLE PHARMACEUTIC ...Tarriff ScottPresident and CEOSellS63.5211,978760,8431,400,7111.4 M to 1.4 M (-0.85 %)
Mar 03 2016EGRXEAGLE PHARMACEUTIC ...Tarriff ScottPresident and CEOSellS62.707,802489,1851,412,6891.4 M to 1.4 M (-0.55 %)
Feb 02 2016EGRXEAGLE PHARMACEUTIC ...Tarriff ScottPresident and CEOSellS71.841,702122,2721,420,4911.4 M to 1.4 M (-0.12 %)

Page:   < prev 1 2 3 next >